Literature DB >> 14506005

Treatment of chronic infections with rifamycins: is resistance likely to follow?

Richard E Chaisson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14506005      PMCID： PMC201148          DOI： 10.1128/AAC.47.10.3037-3039.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  15 in total

1.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

2.  Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates.

Authors:  Zeynep Saribaş; Tanil Kocagöz; Alpaslan Alp; Ayfer Günalp
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 3.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

4.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

5.  Studies of case-finding for pulmonary tuberculosis in outpatients at 4 district hospitals in Kenya.

Authors:  J A Aluoch; O B Swai; E A Edwards; H Stott; J H Darbyshire; W Fox; R J Stephens
Journal:  Tubercle       Date:  1985-12

6.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.

Authors:  H L David
Journal:  Appl Microbiol       Date:  1970-11

Review 7.  New developments in the treatment of latent tuberculosis.

Authors:  R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

8.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Authors:  M A Espinal; S J Kim; P G Suarez; K M Kam; A G Khomenko; G B Migliori; J Baéz; A Kochi; C Dye; M C Raviglione
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

9.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

10.  Tuberculosis drug resistance: a global threat.

Authors:  Jean B Nachega; Richard E Chaisson
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079
View more
  3 in total

1.  Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.

Authors:  Tanil Kocagoz; Zeynep Saribas; Alpaslan Alp
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo.

Authors:  Jagath L Kadurugamuwa; Lin V Sin; Jun Yu; Kevin P Francis; Tony F Purchio; Pamela R Contag
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.